Search

Your search keyword '"Asano, Takaki"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Asano, Takaki" Remove constraint Author: "Asano, Takaki"
157 results on '"Asano, Takaki"'

Search Results

1. Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations

2. Correction to: Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency

3. Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency

4. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

5. Inherited CARD9 Deficiency Due to a Founder Effect in East Asia

6. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

10. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance

11. X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia

13. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency

14. Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC

15. Fatal COVID-19 Infection in Two Children with STAT1 Gain-of-Function

18. Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research.

19. Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity

20. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency

21. A complementary approach for genetic diagnosis of inborn errors of immunity using proteogenomic analysis

22. Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2

23. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study

24. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

26. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

28. Human genetic and immunological determinants of critical COVID-19 pneumonia

29. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

30. Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1.

31. Estimation of Precipitating Electron Energy of Pulsating Aurora Using Ground-based Multiwavelength Optical Observations

32. Isolated congenital asplenia: An overlooked cause of thrombocytosis

33. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

34. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

35. X-linked recessive TLR7 deficiency in similar to 1% of men under 60 years old with life-threatening COVID-19

36. X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia

37. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency

38. HumanSTAT3variants underlie autosomal dominant hyper-IgE syndrome by negative dominance

39. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

40. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

41. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

42. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice

44. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice.

45. Gain-of-function IKBKB mutation causes human combined immune deficiency

46. Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome

47. 主成分分析を用いた脈動オーロラの変調解析

48. Clinical and immunologic phenotype associated with activated ă phosphoinositide 3-kinase delta syndrome 2: A cohort study

49. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: A cohort study

50. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

Catalog

Books, media, physical & digital resources